MENU
CORT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Corcept Therapeutics (CORT) Ownership - Who owns Corcept Therapeutics?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.49B
P/E Ratio
41.59
Total Cash
380.34M
Projected Growth
N/A
Total Debt
6.79M
Revenue
628.56M
Risk (Beta)
0.72
Dividend Yield
N/A
Total Cash/Share
3.63
Total Debt/Equity
374.71
Revenue/Share
5.64 USD as % of share price
Fundamentals
CORT
Capitalization
5.49B
P/E Ratio
41.59
Risk (Beta)
0.72
Dividend Yield
N/A
Total Cash
380M
Total Cash/Share
3.63
Total Debt
6.79M
Total Debt/Equity
374.71
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.64%
Revenue
629M
ROE
N/A
Book Value
639M
P/B Ratio
8.59
Cash Flow
N/A
Earnings
1.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
135K
Current Ratio
3.70
Current Revenue Per Employee
518596.60
Dividends Per Share - Security
N/A
EBITDA
145M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.43
Revenue To Assets
20.39
Shares Held By Institutions
4.81B
Shares Outstanding - Current
105M
Total Liabilities
145M
Total Volume MTD
N/A
Value
-1
Gain YTD
69.766
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a maker of drugs for the treatment of severe psychiatric and neurological diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com